Overview


According to FutureWise analysis the market for alcohol addiction therapeutics is expected to register a CAGR of 6.72% from 2023-2031.

Alcohol addiction therapeutics, also known as alcohol use disorder (AUD), is a medical condition identified by an impaired capability to stop or control alcohol use, even with adverse social, occupational, or health consequences. It encompasses the conditions that some individuals call alcohol addiction, alcohol abuse, alcohol dependence, and the colloquial term, alcoholism. Regarded as a brain disorder, AUD can be mild, moderate, or severe. Enduring effects in the brain caused by alcohol misuse maintain AUD and make individuals susceptible to relapse. The positive aspect is that no matter how severe the problem may seem, evidence-based therapy with behavioral therapies, mutual-support groups, and medications can help individuals with AUD achieve and maintain recovery. For instance, according to the 2021 National Survey on Drug Use and Health, about 28.6 million adults aged 18 and above, which accounts for 11.3% of this age group, experienced AUD in 2021. Among adolescents ages 12 to 17, an estimated 894,000 individuals, constituting (3.4% of this age group) had AUD during this time period.

Cognitive Behavioral Therapy is an evidence-based practice to alleviate the burdens of alcoholism. The basic presumption of cognitive behavioral therapy is the significance of recognizing negative thoughts and behaviors and exchanging them with positive thoughts and behaviors. A CBT session will be a discussion between a patient and a psychologist. Cognitive behavioral therapy (CBT) is a solutions-oriented approach to treatment that focuses less on diagnosis and more on constructive action, such as challenging destructive beliefs, confronting fears, role-playing to improve social interactions, and formulating strategies to quit drinking alcohol or using drugs. Cognitive behavioral therapy is often effective with as few as five sessions.

FutureWise Market Research has published a report that provides an insightful analysis alcohol addiction therapeutics market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, alcohol addiction therapeutics market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • AstraZeneca Plc
  • BioCorRx Inc
  • Bionex Pharmaceuticals LLC
  • Cerecor Inc
  • Chronos Therapeutics Ltd
  • Corcept Therapeutics Inc
  • Curemark LLC
  • Eli Lilly and Company
  • Ethypharm SA
  • H. Lundbeck A/S
  • Heptares Therapeutics Ltd
  • Indivior Plc
  • Kinnov Therapeutics SAS
  • Kyorin Pharmaceutical Co Ltd
  • Lohocla Research Corp
  • Montisera Ltd
  • Omeros Corp
  • Opiant Pharmaceuticals Inc

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Alcohol Addiction Therapeutics Market:

  • In December 2022- BioCoRx Inc., a developer, and supplier of innovative treatment programs for substance abuse and related disorder announced that it has partnered with Government Plud LLC, a leading provider of private sector healthcare to veterans, to expand its Beat Addiction Recovery Program across the country.

  • In November 2022- Indivior PLC and Opiant Pharmaceuticals agreed to strengthen and expand Indivior's position in the market for addiction programs.

The increasing prevalence of alcohol use worldwide is expected to drive the growth of the alcohol addiction therapeutics market during the forecast period. As alcohol consumption continues to be a significant public health concern, with a rising number of individuals developing alcohol use conditions, the demand for effective therapeutics to handle addiction and promote recovery is likely to surge. Moreover, the growing number of rehabilitation centers focused on alcohol addiction treatment is expected to boost market growth significantly. These facilities are crucial in providing specialized care, counselling, and support to individuals seeking recovery from alcohol use disorders. With an increasing emphasis on comprehensive treatment approaches and a shift towards community-based rehabilitation services, the accessibility and availability of these centers are likely to expand, facilitating more individuals to seek professional support for their alcohol addiction. This, in turn, is anticipated to drive the demand for alcohol addiction therapeutics, fostering market growth. Furthermore, the high treatment cost and other factors may hinder the growth of alcohol addiction therapeutics, which may pose a significant barrier for individuals seeking treatment for alcohol use disorders. Expensive therapies and medications might limit access to effective treatment options, especially in developing regions or with limited financial resources. Moreover, the affordability challenges may lead to delayed or incomplete treatment, possibly affecting the overall treatment results and impeding market growth.

By Type

  • CM-1212
  • CTDP-002
  • A-705253
  • ABT-436
  • ADX-71441
  • Others

By Application

  • Hospital
  • Clinic
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Owing to the high prevalence of psychotic substance abuse in the region, the United States is leading the region. Alcohol is the most commonly used abused substance in the U.S. – approximately 7% of the drinking adults and nearly 2% of adolescents in the age group 12-17 years are reported to have AUD. According to The World Bank, the average alcohol consumption per capita aged 15+ years in the U.S. was estimated to be 9.87 liters of pure alcohol in 2018. Moreover, this region has the most extensive rehabilitation facilities in the region is expected to drive the market growth further.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Alcohol Addiction Therapeutics Market By Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Alcohol Addiction Therapeutics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Alcohol Addiction Therapeutics Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Alcohol Addiction Therapeutics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Alcohol Addiction Therapeutics Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. CM-1212
        2. CTDP-002
        3. A-705253
        4. ABT-436
        5. ADX-71441
        6. Others

  • 8.   Global Alcohol Addiction Therapeutics Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital
        2. Clinic
        3. Others

  • 9.   North America Alcohol Addiction Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Alcohol Addiction Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Alcohol Addiction Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Alcohol Addiction Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. AstraZeneca Plc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. BioCorRx Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Bionex Pharmaceuticals LLC
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Cerecor Inc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Chronos Therapeutics Ltd
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Corcept Therapeutics Inc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Curemark LLC
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Eli Lilly and Company
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Ethypharm SA
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. H. Lundbeck A/S
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Heptares Therapeutics Ltd
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Indivior Plc
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Kinnov Therapeutics SAS
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Kyorin Pharmaceutical Co Ltd
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Lohocla Research Corp
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Montisera Ltd
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Omeros Corp
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Opiant Pharmaceuticals Inc
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client

Related Market

Alcohol Breathalyzer and Drug Testing Market

Read More

Alcoholic Hepatitis Therapeutics Market

Read More

Alcohol Dehydrogenase Market

Read More
Partner

Our Clients